{"acute kidney injury": 3.71, "acute respiratory distress syndrome": 6.22, "agranulocytosis": 7.93, "anaemia": 2.04, "aspartate aminotransferase increased": 2.23, "bone marrow failure": 8.03, "colitis": 2.19, "condition aggravated": 2.38, "cytomegalovirus chorioretinitis": 187.59, "cytomegalovirus colitis": 124.49, "cytomegalovirus infection": 61.81, "cytomegalovirus infection reactivation": 103.78, "cytomegalovirus viraemia": 161.53, "cytopenia": 18.39, "depressed level of consciousness": 2.87, "drug ineffective": 3.29, "drug reaction with eosinophilia and systemic symptoms": 6.43, "drug resistance": 81.82, "encephalitis cytomegalovirus": 359.12, "encephalopathy": 6.35, "graft versus host disease": 29.2, "granulocytopenia": 24.54, "haemophagocytic lymphohistiocytosis": 23.66, "hepatic enzyme increased": 2.55, "hepatic function abnormal": 5.69, "hypoxia": 3.2, "intentional product use issue": 6.85, "leukopenia": 16.24, "liver disorder": 3.02, "multiple organ dysfunction syndrome": 11.94, "myelosuppression": 11.82, "nephropathy toxic": 15.47, "neutropenia": 8.69, "neutrophil count decreased": 4.39, "neutrophil pelger-huet anomaly present": 1403.31, "off label use": 4.7, "pancytopenia": 21.55, "pathogen resistance": 91.34, "platelet count decreased": 4.55, "pneumocystis jirovecii pneumonia": 13.97, "pneumonia": 2.21, "pneumonia cytomegaloviral": 121.64, "post transplant lymphoproliferative disorder": 27.36, "product use in unapproved indication": 14.3, "product use issue": 20.81, "pseudomonas infection": 16.25, "renal failure": 2.38, "renal impairment": 4.36, "respiratory failure": 8.14, "retinal detachment": 17.88, "sepsis": 4.98, "septic shock": 6.42, "thrombocytopenia": 7.58, "thrombotic microangiopathy": 14.39, "transplant rejection": 46.72, "treatment failure": 2.01, "viral load increased": 10.96, "viral mutation identified": 41.81, "white blood cell count decreased": 5.96}